Drug-eluting stents vs intracoronary brachytherapy for in-stent restenosis: A meta-analysis

Clinical Cardiology

Volumn 34, Issue 6, 2011, Pages 344-351

  Lu, Yong Guang ^a   Chen, Yan Mei ^a   Li, Lang ^a   Zhao, Rong Zhen ^a   Fu, Chun Hui ^b   Yan, Hua ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; COCHRANE LIBRARY; COMPARATIVE STUDY; CORONARY STENT; DRUG ELUTING STENT; EMBASE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MEDLINE; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958293620     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20900     Document Type: Article

References (30)

1. Kastrati A, Mehilli J, Dirschinger J, et al. Restenosis after coronary placement of various stent types. Am J Cardiol. 2001; 87: 34-39. (Pubitemid 32013081)
2. Liistro F, Fineschi M, Angioli P, et al. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) registry. J Am Coll Cardiol. 2006; 48: 270-275.
3. Aminian A, Kabir T, Eeckhout E., Treatment of drug-eluting stent restenosis: an emerging challenge. Catheter Cardiovasc Interv. 2009; 74: 108-116.
4. Reynen K, Kropp J, Köckeritz U, et al. Intracoronary radiotherapy with a 188Rhenium liquid-filled angioplasty balloon system in in-stent restenosis: a single-center, prospective, randomized, placebo-controlled, double-blind evaluation. Coron Artery Dis. 2006; 17: 371-377. (Pubitemid 44309797)
5. Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 2002; 359: 551-557. (Pubitemid 34178435)
6. Stone GW, Ellis SG, O'Shaughnessy CD, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006; 295: 1253-1263.
7. Holmes DR Jr, Teirstein P, Satler L, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006; 295: 1264-1273.
8. Oliver LN, Buttner PG, Hobson H, et al. A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis. Int J Cardiol. 2008; 126: 216-223. (Pubitemid 351611666)
9. Holmes DR Jr, Teirstein PS, Satler L, et al. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv. 2008; 1: 439-448.
10. Rodriguez AE, Waksman R., Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution? JACC Cardiovasc Interv. 2009; 2: 75-76.
11. Schukro C, Syeda B, Kirisits C, et al. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol. 2007; 82: 18-23. (Pubitemid 46110909)
12. Park SW, Lee SW, Koo BK, et al. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED Study. Int J Cardiol. 2008; 131: 70-77.
13. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62: 1006-1012.
14. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions version 5.0.2 (updated September 2009). Copenhagen, Denmark: The Cochrane Collaboration; 2009.
15. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560. (Pubitemid 37088507)
16. Ellis SG, O'Shaughnessy CD, Martin SL, et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J. 2008; 29: 1625-1634. (Pubitemid 351958446)
17. Feres F, Muñoz JS, Abizaid A, et al. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis. Am J Cardiol. 2005; 96: 1656-1662. (Pubitemid 41790387)
18. Iofina E, Gorchtein V, Radke PW, et al. Advantage of sirolimus-eluting stents compared to intracoronary radiation therapy 30 months after treatment of in-stent restenosis. EuroIntervention. 2007; 2: 467-473.
19. Lee SW, Park SW, Park DW, et al. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis. Am J Cardiol. 2007; 100: 425-430.
20. Pohl T, Kupatt C, Steinbeck G, et al. Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy. Z Kardiol. 2005; 94: 405-410. (Pubitemid 40921969)
21. Radke PW, Kobella S, Kaiser A, et al. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. Eur Heart J. 2004; 25: 920-925. (Pubitemid 38857865)
22. Saia F, Lemos PA, Hoye A, et al. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv. 2004; 62: 283-288. (Pubitemid 38868859)
23. Torguson R, Sabate M, Deible R, et al. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol. 2006; 98: 1340-1344. (Pubitemid 44666639)
24. Zavalloni D, Belli G, Rossi ML, et al. Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes. Am Heart J. 2006; 152: 908.e1-e7.
25. Vom Dahl J, Dietz U, Haager PK, et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation. 2002; 105: 583-588. (Pubitemid 34123432)
26. Albiero R, Silber S, Di Mario C, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol. 2004; 43: 943-949. (Pubitemid 38352970)
27. Giri S, Ito S, Lansky AJ, et al. Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry. Catheter Cardiovasc Interv. 2001; 52: 24-34. (Pubitemid 32066472)
28. Uchida T, Bakhai A, Almonacid A, et al. A meta-analysis of randomized controlled trials of intracoronary gamma-and beta-radiation therapy for in-stent restenosis. Heart Vessels. 2006; 21: 368-374.
29. Waksman R, Ajani AE, Pinnow E, et al. Twelve versus six months of clopidogrel to reduce cardiac major events in patients undergoing radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation. 2002; 106: 776-778.
30. Nishihira K, Shibata Y, Ishikawa T, et al. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis. Circ J. 2010; 74: 2329-2333.